Erba Mannheim Showcases New Launches at MEDICA 2019
|
By LabMedica International staff writers Posted on 20 Nov 2019 |

Image: Electrolyte Analyser EC90 (Photo courtesy of Erba Mannheim)
Erba Mannheim (London, UK) showcased some exciting new launches and provided a preview of NEXUS, its future generation of hematology, chemistry and immunoassay systems, at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. MEDICA is the world's largest annual medical technology trade fair and provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care. The combination of product shows with international congresses, forums, as well as expert workshops, and the exchange of professional views make MEDICA a meeting point for international professionals from various fields in the medical sector.
Erba Mannheim is an emerging player in the global IVD market and offers innovative solutions for lab diagnostics. At MEDICA 2019, the company showcased some of its new launches, including its new EC90 electrolyte analyzer with maintenance-free electrodes in an all-in-one sensor cartridge that is aimed at labs of all sizes. The EC 90 directly measures Na+, Cl-, K+ and Ca2+ from whole blood, plasma, serum and pre-diluted urine using a sensor incorporating thick film technology. The ‘plug and play’ sensor cartridge is integrated into a new reagent pack capable of performing up to 3,000 samples, with a market leading on-board lifetime of three months. No maintenance or cleaning of the pack is required, and waste is self-contained. The EC 90 can analyze samples in 35 seconds, with a typical throughput of 90 samples/hour, and has 35µL and 70µL sample volume measuring modes. Results can be given with a resolution of 0.1mmol/L for Na+ and Cl-, 0.01mmol/L for K+ and Ca2+, and are reproducible with CV< 1%. Small and lightweight (337 x 273 x 422mm, <8kg), the EC 90 features an 8.5-inch color touchscreen display, LIS connectivity, automatic calibration, two USB ports, on-board 24 column thermal printer and a serial port.
Erba Mannheim also showcased the ELAN 30s, a new fully automated compact benchtop ELISA microstrip processor with easy-to-use software, including QC reports and the ability to perform six different tests simultaneously. ELAN 30s eliminates the need for a ELISA reader and washer, making it the ultimate automated solution for labs with small, medium and varied ELISA workloads.
Also on display at this year’s MEDICA was Erba Mannheim’s XL 200 fully automated random access clinical chemistry analyzer with a throughput of 200 tests/hour (photometric test) and 400 tests/hour with ISE (Na/K/Cl/Li). The XL 200 offers 30 position reagent tray with on-board cooling, convenient software and an extensive quality control menu.
At MEDICA 2019, Erba Mannheim provided a preview of its new NEXUS advanced automation range. NEXUS will provide labs with a modular solution designed to deliver mid-scale, advanced-automation across immunology, clinical chemistry and hematology, using a powerful array of technology such as advanced imaging, artificial intelligence, thick film ISE and high sensitivity magnetic beads for CLIA analysis.
Related Links:
Erba Mannheim
Erba Mannheim is an emerging player in the global IVD market and offers innovative solutions for lab diagnostics. At MEDICA 2019, the company showcased some of its new launches, including its new EC90 electrolyte analyzer with maintenance-free electrodes in an all-in-one sensor cartridge that is aimed at labs of all sizes. The EC 90 directly measures Na+, Cl-, K+ and Ca2+ from whole blood, plasma, serum and pre-diluted urine using a sensor incorporating thick film technology. The ‘plug and play’ sensor cartridge is integrated into a new reagent pack capable of performing up to 3,000 samples, with a market leading on-board lifetime of three months. No maintenance or cleaning of the pack is required, and waste is self-contained. The EC 90 can analyze samples in 35 seconds, with a typical throughput of 90 samples/hour, and has 35µL and 70µL sample volume measuring modes. Results can be given with a resolution of 0.1mmol/L for Na+ and Cl-, 0.01mmol/L for K+ and Ca2+, and are reproducible with CV< 1%. Small and lightweight (337 x 273 x 422mm, <8kg), the EC 90 features an 8.5-inch color touchscreen display, LIS connectivity, automatic calibration, two USB ports, on-board 24 column thermal printer and a serial port.
Erba Mannheim also showcased the ELAN 30s, a new fully automated compact benchtop ELISA microstrip processor with easy-to-use software, including QC reports and the ability to perform six different tests simultaneously. ELAN 30s eliminates the need for a ELISA reader and washer, making it the ultimate automated solution for labs with small, medium and varied ELISA workloads.
Also on display at this year’s MEDICA was Erba Mannheim’s XL 200 fully automated random access clinical chemistry analyzer with a throughput of 200 tests/hour (photometric test) and 400 tests/hour with ISE (Na/K/Cl/Li). The XL 200 offers 30 position reagent tray with on-board cooling, convenient software and an extensive quality control menu.
At MEDICA 2019, Erba Mannheim provided a preview of its new NEXUS advanced automation range. NEXUS will provide labs with a modular solution designed to deliver mid-scale, advanced-automation across immunology, clinical chemistry and hematology, using a powerful array of technology such as advanced imaging, artificial intelligence, thick film ISE and high sensitivity magnetic beads for CLIA analysis.
Related Links:
Erba Mannheim
Latest Medica 2019 News
- Mast Group Introduces New MAST CARBA PAcE for Rapid Carbapenemase Detection
- DRG Instruments Demonstrates DRG:HYBRID-XL Fully Automated Lab Analyzer
- Diatron Introduces New Aquila 5Dretic 5-Part Differential Hematology Analyzer
- Alifax S.r.l. Highlights First Automated System for Bacterial Culture and Susceptibility Testing
- EUROIMMUN Showcases Immunoassay Testing Products at MEDICA 2019
- Diconex S.A. Exhibits InCCA Intelligent Clinical Chemistry Analyzer at MEDICA 2019
- Chembio Diagnostics Showcases New DPP Line of Rapid Tests at MEDICA 2019
- DYNEX Demonstrates DYNABLOT Automatic Analyzer for Immunoblot and Westernblot Methods
- Systec Launches New and Improved HX-150 Autoclave at MEDICA 2019
- TaiDoc Showcases Multi-Parameter Monitoring Systems and Advanced Devices
- IDS Exhibits Next Generation Automated Immunoanalyzer IDS-i10 at MEDICA 2019
- JEOL Ltd. Introduces BioMajesty Series of Clinical Chemistry Analyzers at MEDICA 2019
- EKF Diagnostics Showcases Full Product Range at MEDICA 2019
Channels
Clinical Chemistry
view channel
Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
Dementia affects more than 57 million people worldwide and is projected to nearly double within two decades, straining health systems and families. While biomarkers now enable accurate identification of... Read more
Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
High blood pressure during pregnancy is common and can progress to pre-eclampsia, making close monitoring at antenatal visits essential. However, most risk assessment begins only after pregnancy has started.... Read moreMolecular Diagnostics
view channel
Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring
Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response
Immunotherapy has transformed cancer care, yet durable benefit remains limited to a subset of patients, and clinicians still lack reliable tools to predict response before treatment begins.... Read more
Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing
Respiratory infections drive heavy testing volumes in clinical laboratories, where accurate, timely results across multiple pathogens are essential. Many labs are seeking to streamline workflows and increase... Read moreHematology
view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read more
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Bone marrow biopsies remain central to diagnosing and monitoring multiple myeloma, yet the procedure is painful, invasive, and often repeated over time. Older patients—who represent most new cases—can... Read moreImmunology
view channel
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
Mpox outbreaks in non-endemic regions have underscored the need for rapid, accessible diagnostics to limit transmission. Polymerase chain reaction (PCR) remains the clinical reference, yet it depends on... Read more
T-Cell Senescence Profiling May Predict CAR T Responses
Chimeric antigen receptor (CAR) T-cell therapy can deliver striking, durable remissions, yet many patients experience minimal or no benefit. The quality of patient-derived cytotoxic T lymphocytes used... Read moreMicrobiology
view channel
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreTechnology
view channel
Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
Pancreatic cancer remains one of the hardest malignancies to treat because tumors are embedded within a dense microenvironment that shapes growth and therapy response. Standard laboratory models often... Read more
New Platform Captures Extracellular Vesicles for Early Cancer Detection
Early diagnosis remains the most effective way to reduce cancer mortality, yet many screening tools miss disease at its earliest stages. Biomarkers shed by tumors into blood and other fluids can be scarce... Read moreIndustry
view channel
Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
Roche has entered into a definitive merger agreement to acquire PathAI, a company focused on digital pathology and artificial intelligence for pathology laboratories and the biopharma industry.... Read more









